$KYMR
Kymera Therapeutics, Inc.

2024 Q4 Form 10-Q Financial Statement

#000095017024119249 Filed on October 31, 2024

View on sec.gov

Income Statement

Concept 2024 Q4 2024 Q3
Revenue $3.741M
YoY Change -20.88%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $15.46M
YoY Change 9.45%
% of Gross Profit
Research & Development $60.41M
YoY Change 25.55%
% of Gross Profit
Depreciation & Amortization $2.000M
YoY Change 122.22%
% of Gross Profit
Operating Expenses $75.87M
YoY Change 21.9%
Operating Profit -$72.12M
YoY Change 25.41%
Interest Expense $9.637M
YoY Change 107.69%
% of Operating Profit
Other Income/Expense, Net $9.637M
YoY Change 107.6%
Pretax Income -$62.49M
YoY Change 18.19%
Income Tax
% Of Pretax Income
Net Earnings -$62.49M
YoY Change 18.2%
Net Earnings / Revenue -1670.33%
Basic Earnings Per Share -$0.82
Diluted Earnings Per Share -$0.82
COMMON SHARES
Basic Shares Outstanding 64.77M 61.75M
Diluted Shares Outstanding 76.13M

Balance Sheet

Concept 2024 Q4 2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $550.0M
YoY Change 53.7%
Cash & Equivalents $110.7M
Short-Term Investments $439.3M
Other Short-Term Assets $17.43M
YoY Change 23.6%
Inventory
Prepaid Expenses
Receivables $0.00
Other Receivables $0.00
Total Short-Term Assets $568.7M
YoY Change 51.38%
LONG-TERM ASSETS
Property, Plant & Equipment $51.24M
YoY Change 41.77%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $361.0M
YoY Change 368.88%
Other Assets $0.00
YoY Change -100.0%
Total Long-Term Assets $466.1M
YoY Change 163.82%
TOTAL ASSETS
Total Short-Term Assets $568.7M
Total Long-Term Assets $466.1M
Total Assets $1.035B
YoY Change 87.34%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $6.494M
YoY Change 30.45%
Accrued Expenses $26.53M
YoY Change 0.56%
Deferred Revenue $20.02M
YoY Change -26.79%
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due $1.343M
YoY Change 34.3%
Total Short-Term Liabilities $66.53M
YoY Change 5.33%
LONG-TERM LIABILITIES
Long-Term Debt $1.744M
YoY Change 190.67%
Other Long-Term Liabilities $73.64M
YoY Change 920350.0%
Total Long-Term Liabilities $75.38M
YoY Change 942150.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $66.53M
Total Long-Term Liabilities $75.38M
Total Liabilities $141.9M
YoY Change -9.52%
SHAREHOLDERS EQUITY
Retained Earnings -$683.9M
YoY Change 32.44%
Common Stock $1.575B
YoY Change 72.23%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $892.9M
YoY Change
Total Liabilities & Shareholders Equity $1.035B
YoY Change 87.34%

Cashflow Statement

Concept 2024 Q4 2024 Q3
OPERATING ACTIVITIES
Net Income -$62.49M
YoY Change 18.2%
Depreciation, Depletion And Amortization $2.000M
YoY Change 122.22%
Cash From Operating Activities -$50.19M
YoY Change 58.33%
INVESTING ACTIVITIES
Capital Expenditures -$189.0K
YoY Change -102.33%
Acquisitions
YoY Change
Other Investing Activities -$157.9M
YoY Change -330.13%
Cash From Investing Activities -$157.7M
YoY Change -360.63%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 250.9M
YoY Change -125559.0%
NET CHANGE
Cash From Operating Activities -50.19M
Cash From Investing Activities -157.7M
Cash From Financing Activities 250.9M
Net Change In Cash 43.05M
YoY Change 50.52%
FREE CASH FLOW
Cash From Operating Activities -$50.19M
Capital Expenditures -$189.0K
Free Cash Flow -$50.00M
YoY Change 25.63%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Central Index Key
EntityCentralIndexKey
0001815442
CY2024Q3 us-gaap Revenue From Contract With Customer Product And Service Extensible List
RevenueFromContractWithCustomerProductAndServiceExtensibleList
http://fasb.org/us-gaap/2024#RelatedPartyMember
CY2023Q3 us-gaap Revenue From Contract With Customer Product And Service Extensible List
RevenueFromContractWithCustomerProductAndServiceExtensibleList
http://fasb.org/us-gaap/2024#RelatedPartyMember
us-gaap Revenue From Contract With Customer Product And Service Extensible List
RevenueFromContractWithCustomerProductAndServiceExtensibleList
http://fasb.org/us-gaap/2024#RelatedPartyMember
us-gaap Revenue From Contract With Customer Product And Service Extensible List
RevenueFromContractWithCustomerProductAndServiceExtensibleList
http://fasb.org/us-gaap/2024#RelatedPartyMember
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-39460
dei Entity Registrant Name
EntityRegistrantName
KYMERA THERAPEUTICS, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
81-2992166
dei Entity Address Address Line1
EntityAddressAddressLine1
500 North Beacon Street
dei Entity Address Address Line2
EntityAddressAddressLine2
4th Floor
dei Entity Address City Or Town
EntityAddressCityOrTown
Watertown
dei Entity Address State Or Province
EntityAddressStateOrProvince
MA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
02472
dei City Area Code
CityAreaCode
857
dei Local Phone Number
LocalPhoneNumber
285-5300
dei Security12b Title
Security12bTitle
Common Stock, par value $0.0001 per share
dei Trading Symbol
TradingSymbol
KYMR
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
64765274
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
110718000
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
109966000
CY2024Q3 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
439252000
CY2023Q4 us-gaap Available For Sale Securities Debt Securities Current
AvailableForSaleSecuritiesDebtSecuritiesCurrent
264915000
CY2024Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
0
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
15000000
CY2024Q3 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
1317000
CY2023Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
3762000
CY2024Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
17428000
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
11674000
CY2024Q3 us-gaap Assets Current
AssetsCurrent
568715000
CY2023Q4 us-gaap Assets Current
AssetsCurrent
405317000
CY2024Q3 us-gaap Available For Sale Securities Debt Securities Noncurrent
AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
361035000
CY2023Q4 us-gaap Available For Sale Securities Debt Securities Noncurrent
AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
61434000
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
51244000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
48134000
CY2024Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
48065000
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
52945000
CY2024Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
0
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2118000
CY2024Q3 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
5783000
CY2023Q4 us-gaap Restricted Cash Noncurrent
RestrictedCashNoncurrent
5811000
CY2024Q3 us-gaap Assets
Assets
1034842000
CY2023Q4 us-gaap Assets
Assets
575759000
CY2024Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
6494000
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
7075000
CY2024Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
26530000
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
33864000
CY2024Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
20024000
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
37883000
CY2024Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
11508000
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
5068000
CY2024Q3 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
1343000
CY2023Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
1277000
CY2024Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
633000
CY2023Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
524000
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
66532000
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
85691000
CY2024Q3 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
0
CY2023Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
16768000
CY2024Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
73636000
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
77028000
CY2024Q3 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
1744000
CY2023Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
1301000
CY2024Q3 us-gaap Liabilities
Liabilities
141912000
CY2023Q4 us-gaap Liabilities
Liabilities
180788000
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
64748226
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
64748226
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
55390259
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
55390259
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
7000
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
6000
CY2024Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1574850000
CY2023Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
926269000
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-683858000
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-530752000
CY2024Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
1931000
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-552000
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
892930000
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
7000
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
6000
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-683858000
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-530752000
CY2024Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
1931000
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-552000
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
892930000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
394971000
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1034842000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
394971000
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
575759000
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
575759000
CY2024Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3741000
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4728000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
39678000
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4728000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
39678000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
30707000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
30707000
CY2024Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
60410000
CY2023Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
48117000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
168431000
CY2023Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
48117000
CY2024Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
15455000
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
14120000
us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
4925000
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
62237000
us-gaap Operating Expenses
OperatingExpenses
220558000
us-gaap Operating Expenses
OperatingExpenses
176925000
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-72124000
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-57509000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
136111000
CY2024Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
15455000
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
14120000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
47202000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
40814000
CY2024Q3 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2023Q3 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
4925000
us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2024Q3 us-gaap Operating Expenses
OperatingExpenses
75865000
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
62237000
us-gaap Operating Expenses
OperatingExpenses
220558000
us-gaap Operating Income Loss
OperatingIncomeLoss
-180880000
us-gaap Operating Income Loss
OperatingIncomeLoss
-146218000
us-gaap Operating Income Loss
OperatingIncomeLoss
-180880000
us-gaap Operating Income Loss
OperatingIncomeLoss
-146218000
CY2024Q3 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
9697000
CY2023Q3 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
4683000
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
27964000
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
13768000
CY2024Q3 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
60000
CY2023Q3 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
41000
us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
190000
CY2024Q3 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
9697000
CY2023Q3 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
4683000
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
27964000
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
13768000
CY2024Q3 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
60000
CY2023Q3 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
41000
us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
190000
us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
144000
CY2024Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
9637000
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
4642000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
27774000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
13624000
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-62487000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-52867000
us-gaap Net Income Loss
NetIncomeLoss
-153106000
us-gaap Net Income Loss
NetIncomeLoss
-132594000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
13624000
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-62487000
us-gaap Net Income Loss
NetIncomeLoss
-153106000
us-gaap Net Income Loss
NetIncomeLoss
-132594000
CY2023Q3 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
1185000
us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
2483000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-150623000
CY2024Q3 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
4030000
CY2023Q3 us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
1185000
us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
2483000
us-gaap Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent
2499000
CY2024Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-58457000
CY2023Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-51682000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-150623000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-130095000
CY2024Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-62487000
CY2023Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-52867000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-153106000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-132594000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-130095000
CY2024Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-62487000
CY2023Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-52867000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-153106000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-132594000
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.82
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.82
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.9
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.9
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.09
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.09
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.27
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.27
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.82
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.82
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.09
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
58421859
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
58421859
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
73330338
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
76125975
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
76125975
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
58421859
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
58421859
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
73330338
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
73330338
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
58312813
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
58312813
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
435428000
CY2023Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
135000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
58312813
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
435428000
CY2023Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
135000
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
11654000
CY2023Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
1185000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-52867000
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
395535000
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
684924000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
394971000
kymr Proceeds From Issuance Of Common Stock Under Atm
ProceedsFromIssuanceOfCommonStockUnderATM
1200000
kymr Issuance Of Common Stock Under Atm Net Of Issuance Costs Amount
IssuanceOfCommonStockUnderATMNetOfIssuanceCostsAmount
48740000
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
9616000
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
1134000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
41213000
kymr Premiums And Discounts On Available For Sale Marketable Securities
PremiumsAndDiscountsOnAvailableForSaleMarketableSecurities
-10716000
kymr Premiums And Discounts On Available For Sale Marketable Securities
PremiumsAndDiscountsOnAvailableForSaleMarketableSecurities
-3960000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
5754000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
4378000
us-gaap Increase Decrease In Due From Related Parties
IncreaseDecreaseInDueFromRelatedParties
-15000000
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-2118000
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
0
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
198000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
507000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-4842000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-3613000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-34627000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-19487000
kymr Increase Decrease In Operating Lease Right Of Use Assets
IncreaseDecreaseInOperatingLeaseRightOfUseAssets
-1883000
kymr Increase Decrease In Operating Lease Right Of Use Assets
IncreaseDecreaseInOperatingLeaseRightOfUseAssets
-2787000
kymr Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
3048000
kymr Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
15675000
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
-112000
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
-539000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-132717000
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
11654000
CY2023Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
1185000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-52867000
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
395535000
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
684924000
CY2024Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
5053000
CY2024Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
14904000
CY2024Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
4030000
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-62487000
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
892930000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
490151000
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
2297000
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
962000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
32220000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
2499000
us-gaap Net Income Loss
NetIncomeLoss
-132594000
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
395535000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
394971000
kymr Proceeds From Issuance Of Common Stock Under Atm
ProceedsFromIssuanceOfCommonStockUnderATM
1200000
kymr Issuance Of Common Stock Under Atm Net Of Issuance Costs Amount
IssuanceOfCommonStockUnderATMNetOfIssuanceCostsAmount
48740000
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
9616000
us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
1134000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
41213000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
2483000
us-gaap Net Income Loss
NetIncomeLoss
-153106000
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
892930000
us-gaap Profit Loss
ProfitLoss
-153106000
us-gaap Profit Loss
ProfitLoss
-132594000
us-gaap Share Based Compensation
ShareBasedCompensation
41213000
us-gaap Share Based Compensation
ShareBasedCompensation
32220000
us-gaap Asset Impairment Charges
AssetImpairmentCharges
4925000
us-gaap Asset Impairment Charges
AssetImpairmentCharges
0
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
5386000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2674000
kymr Premiums And Discounts On Available For Sale Marketable Securities
PremiumsAndDiscountsOnAvailableForSaleMarketableSecurities
-10716000
kymr Premiums And Discounts On Available For Sale Marketable Securities
PremiumsAndDiscountsOnAvailableForSaleMarketableSecurities
-3960000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
5754000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
4378000
us-gaap Increase Decrease In Due From Related Parties
IncreaseDecreaseInDueFromRelatedParties
-15000000
us-gaap Increase Decrease In Due From Related Parties
IncreaseDecreaseInDueFromRelatedParties
0
kymr Increase Decrease In Contract With Customer Asset Related Parties
IncreaseDecreaseInContractWithCustomerAssetRelatedParties
-2445000
kymr Increase Decrease In Contract With Customer Asset Related Parties
IncreaseDecreaseInContractWithCustomerAssetRelatedParties
1241000
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-2118000
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
0
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
198000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
507000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-4842000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-3613000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-34627000
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-19487000
kymr Increase Decrease In Operating Lease Right Of Use Assets
IncreaseDecreaseInOperatingLeaseRightOfUseAssets
-1883000
kymr Increase Decrease In Operating Lease Right Of Use Assets
IncreaseDecreaseInOperatingLeaseRightOfUseAssets
-2787000
kymr Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
3048000
kymr Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
15675000
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
-112000
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
-539000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-132717000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-110871000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
11902000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
22855000
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
822804000
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
143647000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-472645000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
120934000
kymr Issuance Of Common Stock At Private Placement Net Of Issuance Cost
IssuanceOfCommonStockAtPrivatePlacementNetOfIssuanceCost
-301373000
kymr Issuance Of Common Stock At Private Placement Net Of Issuance Cost
IssuanceOfCommonStockAtPrivatePlacementNetOfIssuanceCost
0
kymr Proceeds From Issuance Of Common Stock Under Atm
ProceedsFromIssuanceOfCommonStockUnderATM
1200000
kymr Proceeds From Issuance Of Common Stock Under Atm
ProceedsFromIssuanceOfCommonStockUnderATM
1200000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-110871000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
11902000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
22855000
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
822804000
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
143647000
us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
362061000
us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
287436000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-472645000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
120934000
kymr Issuance Of Common Stock At Private Placement Net Of Issuance Cost
IssuanceOfCommonStockAtPrivatePlacementNetOfIssuanceCost
-301373000
kymr Issuance Of Common Stock At Private Placement Net Of Issuance Cost
IssuanceOfCommonStockAtPrivatePlacementNetOfIssuanceCost
0
kymr Proceeds From Issuance Of Common Stock Under Atm
ProceedsFromIssuanceOfCommonStockUnderATM
1200000
kymr Proceeds From Issuance Of Common Stock Under Atm
ProceedsFromIssuanceOfCommonStockUnderATM
1200000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
48740000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0
kymr Issuance Of Common Stock And Accompanying Pre Funded Warrants From August Two Thousand Twenty Four Public Offering Net Of Issuance Costs
IssuanceOfCommonStockAndAccompanyingPreFundedWarrantsFromAugustTwoThousandTwentyFourPublicOfferingNetOfIssuanceCosts
-246506000
kymr Issuance Of Common Stock And Accompanying Pre Funded Warrants From August Two Thousand Twenty Four Public Offering Net Of Issuance Costs
IssuanceOfCommonStockAndAccompanyingPreFundedWarrantsFromAugustTwoThousandTwentyFourPublicOfferingNetOfIssuanceCosts
0
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
9616000
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
2297000
kymr Proceeds From Employee Stock Purchase Plan
ProceedsFromEmployeeStockPurchasePlan
1134000
kymr Proceeds From Employee Stock Purchase Plan
ProceedsFromEmployeeStockPurchasePlan
962000
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
1283000
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
1001000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
606086000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2258000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
724000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
12321000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
115777000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
74524000
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
116501000
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
86845000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
0
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
48833000
us-gaap Interest Paid Net
InterestPaidNet
144000
us-gaap Interest Paid Net
InterestPaidNet
115000
kymr Property And Equipment Purchases Included In Accounts Payable And Accrued Expenses
PropertyAndEquipmentPurchasesIncludedInAccountsPayableAndAccruedExpenses
744000
kymr Property And Equipment Purchases Included In Accounts Payable And Accrued Expenses
PropertyAndEquipmentPurchasesIncludedInAccountsPayableAndAccruedExpenses
2762000
kymr Purchase Of Property And Equipment Through Finance Lease
PurchaseOfPropertyAndEquipmentThroughFinanceLease
1793000
kymr Purchase Of Property And Equipment Through Finance Lease
PurchaseOfPropertyAndEquipmentThroughFinanceLease
0
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
110718000
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
81051000
CY2024Q3 us-gaap Restricted Cash
RestrictedCash
5783000
CY2023Q3 us-gaap Restricted Cash
RestrictedCash
5794000
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
116501000
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
86845000
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-683900000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
48740000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0
kymr Issuance Of Common Stock And Accompanying Pre Funded Warrants From August Two Thousand Twenty Four Public Offering Net Of Issuance Costs
IssuanceOfCommonStockAndAccompanyingPreFundedWarrantsFromAugustTwoThousandTwentyFourPublicOfferingNetOfIssuanceCosts
-246506000
kymr Issuance Of Common Stock And Accompanying Pre Funded Warrants From August Two Thousand Twenty Four Public Offering Net Of Issuance Costs
IssuanceOfCommonStockAndAccompanyingPreFundedWarrantsFromAugustTwoThousandTwentyFourPublicOfferingNetOfIssuanceCosts
0
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
9616000
us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
2297000
kymr Proceeds From Employee Stock Purchase Plan
ProceedsFromEmployeeStockPurchasePlan
1134000
kymr Proceeds From Employee Stock Purchase Plan
ProceedsFromEmployeeStockPurchasePlan
962000
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
1283000
us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
1001000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
606086000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2258000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
724000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
12321000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
115777000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
74524000
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
116501000
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
86845000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
0
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
48833000
us-gaap Interest Paid Net
InterestPaidNet
144000
us-gaap Interest Paid Net
InterestPaidNet
115000
kymr Property And Equipment Purchases Included In Accounts Payable And Accrued Expenses
PropertyAndEquipmentPurchasesIncludedInAccountsPayableAndAccruedExpenses
744000
kymr Property And Equipment Purchases Included In Accounts Payable And Accrued Expenses
PropertyAndEquipmentPurchasesIncludedInAccountsPayableAndAccruedExpenses
2762000
kymr Purchase Of Property And Equipment Through Finance Lease
PurchaseOfPropertyAndEquipmentThroughFinanceLease
1793000
kymr Purchase Of Property And Equipment Through Finance Lease
PurchaseOfPropertyAndEquipmentThroughFinanceLease
0
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
110718000
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
81051000
CY2024Q3 us-gaap Restricted Cash
RestrictedCash
5783000
CY2023Q3 us-gaap Restricted Cash
RestrictedCash
5794000
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
116501000
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
86845000
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-683900000
CY2024Q3 us-gaap Investments And Cash
InvestmentsAndCash
911000000
CY2024Q3 us-gaap Investments And Cash
InvestmentsAndCash
911000000
CY2024Q3 kymr Fair Value Assets Level3 To Level2 Transfers Amount
FairValueAssetsLevel3ToLevel2TransfersAmount
0
CY2023Q4 kymr Fair Value Assets Level2 To Level3 Transfers Amount
FairValueAssetsLevel2ToLevel3TransfersAmount
0
CY2024Q3 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
798368000
CY2024Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
2334000
CY2024Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
415000
CY2024Q3 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
800287000
CY2023Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
326907000
CY2023Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
166000
CY2023Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
724000
CY2023Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
326349000
CY2024Q3 kymr Fair Value Assets Level3 To Level2 Transfers Amount
FairValueAssetsLevel3ToLevel2TransfersAmount
0
CY2023Q4 kymr Fair Value Assets Level2 To Level3 Transfers Amount
FairValueAssetsLevel2ToLevel3TransfersAmount
0
CY2024Q3 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
798368000
CY2024Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
2334000
CY2024Q3 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
415000
CY2024Q3 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
800287000
CY2023Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
326907000
CY2023Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
166000
CY2023Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
724000
CY2023Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
326349000
CY2024Q3 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Number Of Positions
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
47
CY2024Q3 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
296400000
CY2023Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Number Of Positions
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
109
CY2023Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
229700000
kymr Debt Securities Available For Sale Decline In Market Value For Unrealized Loss Position Number Of Securities
DebtSecuritiesAvailableForSaleDeclineInMarketValueForUnrealizedLossPositionNumberOfSecurities
17
CY2024Q3 kymr Debt Securities Available For Sale Continuous Unrealized Loss Position Greater Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionGreaterThan12Months
32900000
CY2023 kymr Debt Securities Available For Sale Decline In Market Value For Unrealized Loss Position Number Of Securities
DebtSecuritiesAvailableForSaleDeclineInMarketValueForUnrealizedLossPositionNumberOfSecurities
16
CY2023Q4 kymr Debt Securities Available For Sale Continuous Unrealized Loss Position Greater Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionGreaterThan12Months
36600000
CY2024Q3 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Number Of Positions
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
47
CY2024Q3 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
296400000
CY2023Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Number Of Positions
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsNumberOfPositions
109
CY2023Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
229700000
kymr Debt Securities Available For Sale Decline In Market Value For Unrealized Loss Position Number Of Securities
DebtSecuritiesAvailableForSaleDeclineInMarketValueForUnrealizedLossPositionNumberOfSecurities
17
CY2024Q3 kymr Debt Securities Available For Sale Continuous Unrealized Loss Position Greater Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionGreaterThan12Months
32900000
CY2023 kymr Debt Securities Available For Sale Decline In Market Value For Unrealized Loss Position Number Of Securities
DebtSecuritiesAvailableForSaleDeclineInMarketValueForUnrealizedLossPositionNumberOfSecurities
16
CY2023Q4 kymr Debt Securities Available For Sale Continuous Unrealized Loss Position Greater Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionGreaterThan12Months
36600000
kymr Debt Securities Available For Sale Contractual Maturity Of Less Than12 Months Number Of Securities
DebtSecuritiesAvailableForSaleContractualMaturityOfLessThan12MonthsNumberOfSecurities
142
CY2024Q3 kymr Fair Value Of Available For Sale Debt Securities Contractual Maturity Of Less Than Twelve Months
FairValueOfAvailableForSaleDebtSecuritiesContractualMaturityOfLessThanTwelveMonths
439300000
kymr Debt Securities Available For Sale Contractual Maturity Of12 Months Or Longer Number Of Securities
DebtSecuritiesAvailableForSaleContractualMaturityOf12MonthsOrLongerNumberOfSecurities
117
CY2024Q3 us-gaap Available For Sale Securities Debt Securities Noncurrent
AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
361000000
CY2023 kymr Debt Securities Available For Sale Contractual Maturity Of Less Than12 Months Number Of Securities
DebtSecuritiesAvailableForSaleContractualMaturityOfLessThan12MonthsNumberOfSecurities
124
CY2023Q4 kymr Fair Value Of Available For Sale Debt Securities Contractual Maturity Of Less Than Twelve Months
FairValueOfAvailableForSaleDebtSecuritiesContractualMaturityOfLessThanTwelveMonths
264900000
CY2023 kymr Debt Securities Available For Sale Contractual Maturity Of12 Months Or Longer Number Of Securities
DebtSecuritiesAvailableForSaleContractualMaturityOf12MonthsOrLongerNumberOfSecurities
27
CY2023Q4 us-gaap Available For Sale Securities Debt Securities Noncurrent
AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
61400000
CY2024Q3 kymr Available For Sale Securities Credit Losses
AvailableForSaleSecuritiesCreditLosses
0
CY2023Q4 kymr Available For Sale Securities Credit Losses
AvailableForSaleSecuritiesCreditLosses
0
kymr Cost Reimbursement Payment Received
CostReimbursementPaymentReceived
7500000
CY2024Q3 us-gaap Unbilled Contracts Receivable
UnbilledContractsReceivable
1300000
kymr Remaining Research Term Of Collaboration
RemainingResearchTermOfCollaboration
P1Y
CY2024Q3 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
49700000
us-gaap Deferred Revenue Revenue Recognized1
DeferredRevenueRevenueRecognized1
55000000
CY2024Q3 us-gaap Deferred Revenue
DeferredRevenue
5300000
CY2023Q4 us-gaap Contract With Customer Receivable After Allowance For Credit Loss
ContractWithCustomerReceivableAfterAllowanceForCreditLoss
18762000
kymr Contract With Customer Asset Net Additions
ContractWithCustomerAssetNetAdditions
12547000
kymr Contract With Customer Asset Net Deductions
ContractWithCustomerAssetNetDeductions
29992000
CY2024Q3 us-gaap Contract With Customer Receivable After Allowance For Credit Loss
ContractWithCustomerReceivableAfterAllowanceForCreditLoss
1317000
CY2023Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
54651000
kymr Contract With Customer Liability Additions
ContractWithCustomerLiabilityAdditions
5051000
kymr Contract With Customer Liability Deductions
ContractWithCustomerLiabilityDeductions
-39678000
CY2024Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
20024000
CY2024Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
65330000
kymr Debt Securities Available For Sale Contractual Maturity Of Less Than12 Months Number Of Securities
DebtSecuritiesAvailableForSaleContractualMaturityOfLessThan12MonthsNumberOfSecurities
142
CY2024Q3 kymr Fair Value Of Available For Sale Debt Securities Contractual Maturity Of Less Than Twelve Months
FairValueOfAvailableForSaleDebtSecuritiesContractualMaturityOfLessThanTwelveMonths
439300000
kymr Debt Securities Available For Sale Contractual Maturity Of12 Months Or Longer Number Of Securities
DebtSecuritiesAvailableForSaleContractualMaturityOf12MonthsOrLongerNumberOfSecurities
117
CY2024Q3 us-gaap Available For Sale Securities Debt Securities Noncurrent
AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
361000000
CY2023 kymr Debt Securities Available For Sale Contractual Maturity Of Less Than12 Months Number Of Securities
DebtSecuritiesAvailableForSaleContractualMaturityOfLessThan12MonthsNumberOfSecurities
124
CY2023Q4 kymr Fair Value Of Available For Sale Debt Securities Contractual Maturity Of Less Than Twelve Months
FairValueOfAvailableForSaleDebtSecuritiesContractualMaturityOfLessThanTwelveMonths
264900000
CY2023 kymr Debt Securities Available For Sale Contractual Maturity Of12 Months Or Longer Number Of Securities
DebtSecuritiesAvailableForSaleContractualMaturityOf12MonthsOrLongerNumberOfSecurities
27
CY2023Q4 us-gaap Available For Sale Securities Debt Securities Noncurrent
AvailableForSaleSecuritiesDebtSecuritiesNoncurrent
61400000
CY2024Q3 kymr Available For Sale Securities Credit Losses
AvailableForSaleSecuritiesCreditLosses
0
CY2023Q4 kymr Available For Sale Securities Credit Losses
AvailableForSaleSecuritiesCreditLosses
0
kymr Cost Reimbursement Payment Received
CostReimbursementPaymentReceived
7500000
CY2024Q3 us-gaap Unbilled Contracts Receivable
UnbilledContractsReceivable
1300000
kymr Remaining Research Term Of Collaboration
RemainingResearchTermOfCollaboration
P1Y
CY2024Q3 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
49700000
us-gaap Deferred Revenue Revenue Recognized1
DeferredRevenueRevenueRecognized1
55000000
CY2024Q3 us-gaap Deferred Revenue
DeferredRevenue
5300000
CY2023Q4 us-gaap Contract With Customer Receivable After Allowance For Credit Loss
ContractWithCustomerReceivableAfterAllowanceForCreditLoss
18762000
kymr Contract With Customer Asset Net Additions
ContractWithCustomerAssetNetAdditions
12547000
kymr Contract With Customer Asset Net Deductions
ContractWithCustomerAssetNetDeductions
29992000
CY2024Q3 us-gaap Contract With Customer Receivable After Allowance For Credit Loss
ContractWithCustomerReceivableAfterAllowanceForCreditLoss
1317000
CY2023Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
54651000
kymr Contract With Customer Liability Additions
ContractWithCustomerLiabilityAdditions
5051000
kymr Contract With Customer Liability Deductions
ContractWithCustomerLiabilityDeductions
-39678000
CY2024Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
20024000
CY2024Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
65330000
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
58574000
CY2024Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
14086000
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
10440000
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
51244000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
48134000
CY2024Q3 us-gaap Depreciation
Depreciation
2000000
CY2023Q3 us-gaap Depreciation
Depreciation
900000
us-gaap Depreciation
Depreciation
5400000
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
58574000
CY2024Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
14086000
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
10440000
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
51244000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
48134000
CY2024Q3 us-gaap Depreciation
Depreciation
2000000
CY2023Q3 us-gaap Depreciation
Depreciation
900000
us-gaap Depreciation
Depreciation
5400000
us-gaap Depreciation
Depreciation
2700000
CY2024Q3 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
300000
CY2023Q3 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
400000
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
1100000
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
1100000
us-gaap Impairment Charge On Reclassified Assets
ImpairmentChargeOnReclassifiedAssets
4900000
CY2024Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
2493000
CY2023Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
2521000
us-gaap Operating Lease Cost
OperatingLeaseCost
7484000
us-gaap Operating Lease Cost
OperatingLeaseCost
7562000
CY2024Q3 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
314000
CY2023Q3 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
369000
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
1109000
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
1108000
CY2024Q3 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
52000
CY2023Q3 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
37000
us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
137000
us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
133000
CY2024Q3 us-gaap Variable Lease Cost
VariableLeaseCost
1421000
CY2023Q3 us-gaap Variable Lease Cost
VariableLeaseCost
273000
us-gaap Variable Lease Cost
VariableLeaseCost
4011000
us-gaap Variable Lease Cost
VariableLeaseCost
712000
CY2024Q3 us-gaap Lease Cost
LeaseCost
4280000
CY2023Q3 us-gaap Lease Cost
LeaseCost
3200000
us-gaap Lease Cost
LeaseCost
12741000
us-gaap Lease Cost
LeaseCost
9515000
kymr Operating Lease Payments Proceeds
OperatingLeasePaymentsProceeds
6570000
kymr Operating Lease Payments Proceeds
OperatingLeasePaymentsProceeds
1989000
us-gaap Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
1010000
us-gaap Depreciation
Depreciation
2700000
CY2024Q3 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
300000
CY2023Q3 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
400000
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
1100000
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
1100000
us-gaap Impairment Charge On Reclassified Assets
ImpairmentChargeOnReclassifiedAssets
4900000
CY2024Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
2493000
CY2023Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
2521000
us-gaap Operating Lease Cost
OperatingLeaseCost
7484000
us-gaap Operating Lease Cost
OperatingLeaseCost
7562000
CY2024Q3 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
314000
CY2023Q3 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
369000
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
1109000
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
1108000
CY2024Q3 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
52000
CY2023Q3 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
37000
us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
137000
us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
133000
CY2024Q3 us-gaap Variable Lease Cost
VariableLeaseCost
1421000
CY2023Q3 us-gaap Variable Lease Cost
VariableLeaseCost
273000
us-gaap Variable Lease Cost
VariableLeaseCost
4011000
us-gaap Variable Lease Cost
VariableLeaseCost
712000
CY2024Q3 us-gaap Lease Cost
LeaseCost
4280000
us-gaap Lease Cost
LeaseCost
9515000
kymr Operating Lease Payments Proceeds
OperatingLeasePaymentsProceeds
6570000
kymr Operating Lease Payments Proceeds
OperatingLeasePaymentsProceeds
1989000
us-gaap Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
1010000
us-gaap Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
1001000
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
137000
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
133000
us-gaap Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
1001000
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
137000
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
133000
CY2024Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P9Y9M10D
CY2023Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P10Y5M12D
CY2024Q3 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P2Y6M25D
CY2023Q3 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P2Y1M17D
CY2024Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0872
CY2023Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0878
CY2024Q3 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.0858
CY2023Q3 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.0848
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
2954000
CY2024Q3 us-gaap Finance Lease Liability Payments Remainder Of Fiscal Year
FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear
354000
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
12074000
CY2024Q3 us-gaap Finance Lease Liability Payments Due Next Twelve Months
FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
1364000
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
12436000
CY2024Q3 us-gaap Finance Lease Liability Payments Due Year Two
FinanceLeaseLiabilityPaymentsDueYearTwo
1209000
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
12809000
CY2024Q3 us-gaap Finance Lease Liability Payments Due Year Three
FinanceLeaseLiabilityPaymentsDueYearThree
503000
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
13193000
CY2024Q3 us-gaap Finance Lease Liability Payments Due Year Four
FinanceLeaseLiabilityPaymentsDueYearFour
0
CY2024Q3 kymr Lessee Operating Lease Liability Payments Due After Year Four
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour
74424000
CY2024Q3 kymr Finance Lease Liability Payments Due After Year Four
FinanceLeaseLiabilityPaymentsDueAfterYearFour
0
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
127890000
CY2024Q3 us-gaap Finance Lease Liability Payments Due
FinanceLeaseLiabilityPaymentsDue
3430000
CY2024Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
42746000
CY2024Q3 us-gaap Finance Lease Liability Undiscounted Excess Amount
FinanceLeaseLiabilityUndiscountedExcessAmount
343000
CY2024Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
85144000
CY2024Q3 us-gaap Finance Lease Liability
FinanceLeaseLiability
3087000
CY2024Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P9Y9M10D
CY2023Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P10Y5M12D
CY2024Q3 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P2Y6M25D
CY2023Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0878
CY2024Q3 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.0858
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
2954000
CY2024Q3 us-gaap Finance Lease Liability Payments Remainder Of Fiscal Year
FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear
354000
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
12074000
CY2024Q3 us-gaap Finance Lease Liability Payments Due Next Twelve Months
FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
1364000
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
12436000
CY2024Q3 us-gaap Finance Lease Liability Payments Due Year Two
FinanceLeaseLiabilityPaymentsDueYearTwo
1209000
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
12809000
CY2024Q3 us-gaap Finance Lease Liability Payments Due Year Three
FinanceLeaseLiabilityPaymentsDueYearThree
503000
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
13193000
CY2024Q3 us-gaap Finance Lease Liability Payments Due Year Four
FinanceLeaseLiabilityPaymentsDueYearFour
0
CY2024Q3 kymr Finance Lease Liability Payments Due After Year Four
FinanceLeaseLiabilityPaymentsDueAfterYearFour
0
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
127890000
CY2024Q3 us-gaap Finance Lease Liability Payments Due
FinanceLeaseLiabilityPaymentsDue
3430000
CY2024Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
42746000
CY2024Q3 us-gaap Finance Lease Liability Undiscounted Excess Amount
FinanceLeaseLiabilityUndiscountedExcessAmount
343000
CY2024Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
85144000
CY2024Q3 us-gaap Finance Lease Liability
FinanceLeaseLiability
3087000
CY2024Q3 kymr Accrued Research And Development Expenses Current
AccruedResearchAndDevelopmentExpensesCurrent
12612000
CY2023Q4 kymr Accrued Research And Development Expenses Current
AccruedResearchAndDevelopmentExpensesCurrent
15099000
CY2024Q3 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
9530000
CY2023Q4 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
11227000
CY2024Q3 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
3353000
CY2023Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
3854000
CY2024Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1035000
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
3684000
CY2024Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
26530000
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
33864000
CY2024Q3 kymr Accrued Research And Development Expenses Current
AccruedResearchAndDevelopmentExpensesCurrent
12612000
CY2023Q4 kymr Accrued Research And Development Expenses Current
AccruedResearchAndDevelopmentExpensesCurrent
15099000
CY2024Q3 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
9530000
CY2023Q4 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
11227000
CY2024Q3 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
3353000
CY2023Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
3854000
CY2024Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1035000
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
3684000
CY2024Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
26530000
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
33864000
CY2024Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y29D
CY2023Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y29D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y9M14D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y10M9D
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.67
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.62
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.65
CY2024Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y29D
CY2023Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y29D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y9M14D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y10M9D
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.67
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.65
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.62
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0412
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0406
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2024Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
14904000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
41213000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
32220000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.62
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0369
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0414
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0412
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0406
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2024Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
14904000
CY2023Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
11655000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
41213000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
32220000
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-62487000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-52867000
us-gaap Net Income Loss
NetIncomeLoss
-153106000
us-gaap Net Income Loss
NetIncomeLoss
-132594000
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
76125975
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
76125975
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
58421859
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
58421859
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
73330338
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
73330338
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
58312813
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
58312813
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.82
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.82
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.9
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.9
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.09
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.27
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.27
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
10406863
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
8837606
CY2024Q3 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q3 kymr Rule10 B51 Arr Modified Flag
Rule10B51ArrModifiedFlag
false
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-62487000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-52867000
us-gaap Net Income Loss
NetIncomeLoss
-153106000
us-gaap Net Income Loss
NetIncomeLoss
-132594000
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
76125975
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
76125975
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
58421859
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
58421859
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
73330338
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
73330338
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
58312813
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
58312813
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.82
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.82
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.9
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.9
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.09
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.09
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.27
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.27
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
10406863
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
8837606
CY2024Q3 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q3 kymr Rule10 B51 Arr Modified Flag
Rule10B51ArrModifiedFlag
false
CY2024Q3 kymr Nonrule10 B51 Arr Modified Flag
Nonrule10B51ArrModifiedFlag
false
CY2024Q3 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2024Q3 kymr Nonrule10 B51 Arr Modified Flag
Nonrule10B51ArrModifiedFlag
false
CY2024Q3 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0000950170-24-119249-index-headers.html Edgar Link pending
0000950170-24-119249-index.html Edgar Link pending
0000950170-24-119249.txt Edgar Link pending
0000950170-24-119249-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
kymr-20240930.htm Edgar Link pending
kymr-20240930.xsd Edgar Link pending
kymr-ex10_1.htm Edgar Link pending
kymr-ex10_2.htm Edgar Link pending
kymr-ex31_1.htm Edgar Link pending
kymr-ex31_2.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
kymr-20240930_htm.xml Edgar Link completed
kymr-ex32_1.htm Edgar Link pending
kymr-ex32_2.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending